Haemonetics
197 hedge funds and large institutions have $2.19B invested in Haemonetics in 2017 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 89 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 181 → 197 (+16)
0.59% more ownership
Funds ownership: 105.07% → 105.66% (+0.59%)
1% less capital invested
Capital invested by funds: $2.22B → $2.19B (-$26.1M)
Holders
197
Holding in Top 10
3
Calls
$6K
Puts
$4K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$10.1M | |
| 3 | +$9.41M | |
| 4 |
Morgan Stanley
New York
|
+$9.11M |
| 5 |
ACA
Anchor Capital Advisors
Boston,
Massachusetts
|
+$9M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$14.2M | |
| 3 | -$9.53M | |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$8.88M |
| 5 |
Millennium Management
New York
|
-$8.12M |